Federal Register: April 18, 2005 (Volume 70, Number 73)
DOCID: FR Doc 05-7608
DEPARTMENT OF DEFENSE
Army Department
NOTICE: NOTICES
DOCUMENT ACTION: Notice.
SUBJECT CATEGORY:
Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Prophylactic and Therapeutic Monoclonal Antibodies
DOCUMENT SUMMARY:
In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of U.S. Patent Application No. 10/987,533 entitled ``Prophylactic and Therapeutic Monoclonal Antibodies,'' filed November 12, 2004. Foreign rights are also available (PCT/US04/38480). The United States Government, as represented by the Secretary of the Army, has rights in this invention.
SUMMARY:
Inventions, Government-owned; availability for licensing,
SUPPLEMENTAL INFORMATION
In this application are described monoclonal
antibodies which specifically recognize V antigen of Y pestis and
epitopes recognized by these monoclonal antibodies. Also provided are
mixtures of antibodies of the present invention, as well as methods of
using individual antibodies or mixtures thereof for the detection,
prevention, and/or therapeutical treatment of plague infections in vitro and in vivo.
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 057608 Filed 41505; 8:45 am]
BILLING CODE 371008M
FOR FURTHER INFORMATION CONTACT
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 6197808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 6196664, both at telefax (301) 6195034.